EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access

Surgery or endovascular therapy for patients with chronic limb-threatening ischemia requiring infrapopliteal interventions

Kristina A Giles, Alik Farber, Matthew T Menard, Michael S Conte, Brian W Nolan, Jeffrey J Siracuse, Michael B Strong, Gheorghe Doros, Maarit Venermo, Ezana Azene, Kenneth Rosenfield, Richard J Powell

Journal of Vascular Surgery · 2024-11 · 80 (5) · 1515-1524

DOI: 10.1016/j.jvs.2024.05.049 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Vascular Surgery, 2024-11. Verfasst von Kristina A Giles und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Vascular and Endovascular Surgery, Maine Medical Center, Portland, ME. Electronic address: Kristina.Giles@MaineHealth.org. Hauptthemen laut MEDLINE: Amputation, Surgical, Limb Salvage, Peripheral Arterial Disease, Chronic Limb-Threatening Ischemia. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NHLBI, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: The recent publication of randomized trials comparing open bypass surgery to endovascular therapy in patients with chronic limb-threatening ischemia, namely, Best Endovascular vs Best Surgical Therapy in Patients with Critical Limb Ischemia (BEST-CLI) and Bypass versus Angioplasty in Severe Ischaemia of the Leg-2 (BASIL-2), has resulted in potentially contradictory findings. The trials differed significantly with respect to anatomical disease patterns and primary end points. We performed an analysis of patients in BEST-CLI with significant infrapopliteal disease undergoing open tibial bypass or endovascular tibial interventions to formulate a relevant comparator with the outcomes reported from BASIL-2. METHODS: The study population consisted of patients in BEST-CLI with adequate single segment saphenous vein conduit randomized to open bypass or endovascular intervention (cohort 1) who additionally had significant infrapopliteal disease and underwent tibial level intervention. The primary outcome was major adverse limb event (MALE) or all-cause death. MALE included any major limb amputation or major reintervention. Outcomes were evaluated using Cox proportional regression models. RESULTS: The analyzed subgroup included a total of 665 patients with 326 in the open tibial bypass group and 339 in the tibial endovascular intervention group. The primary outcome of MALE or all-cause death at 3 years was significantly lower in the surgical group at 48.5% compared with 56.7% in the endovascular group (P = .0018). Mortality was similar between groups (35.5% open vs 35.8% endovascular; P = .94), whereas MALE events were lower in the surgical group (23.3% vs 35.0%; P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amputation, SurgicalLimb SalvagePeripheral Arterial DiseaseChronic Limb-Threatening IschemiaPopliteal ArterySaphenous VeinEndovascular ProceduresHumansMaleFemaleAgedTime FactorsRisk FactorsTreatment OutcomeMiddle AgedProportional Hazards ModelsKaplan-Meier EstimateVascular GraftingAged, 80 and overIschemiaChronic DiseaseVascular PatencyProgression-Free SurvivalCritical Illness

Stichwörter der Autor:innen

Amputation-free survivalBASIL-2BEST-CLIChronic limb-threatening ischemiaInfrapopliteal diseaseMajor adverse limb eventsTibial bypassTibial diseaseTibial endovascular intervention

Autor:innen und Institutionen

  • Division of Vascular and Endovascular Surgery, Maine Medical Center, Portland, ME. Electronic address: Kristina.Giles@MaineHealth.org.
  • Division of Vascular and Endovascular Surgery, Boston Medical Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA.
  • Division of Vascular and Endovascular Surgery, Brigham and Woman's Hospital, Boston, MA.
  • Division of Vascular and Endovascular Surgery, University of California San Francisco.
  • Division of Vascular and Endovascular Surgery, Maine Medical Center, Portland, ME.
  • Brigham and Woman's Hospital, Boston, MA.

Förderung

  • NHLBI NIH HHS
  • NHLBI
  • National Institutes of Health
  • Novo Nordisk Fonden
  • BD

Zitieren

APA

Giles, K. A., Farber, A., Menard, M. T., Conte, M. S., Nolan, B. W., Siracuse, J. J., Strong, M. B., Doros, G., Venermo, M., Azene, E., Rosenfield, K., & Powell, R. J. (2024). Surgery or endovascular therapy for patients with chronic limb-threatening ischemia requiring infrapopliteal interventions. Journal of Vascular Surgery, 80(5), 1515-1524. https://doi.org/10.1016/j.jvs.2024.05.049

Vancouver

Giles KA, Farber A, Menard MT, Conte MS, Nolan BW, Siracuse JJ, et al. Surgery or endovascular therapy for patients with chronic limb-threatening ischemia requiring infrapopliteal interventions. Journal of Vascular Surgery. 2024;80(5):1515-1524. doi:10.1016/j.jvs.2024.05.049

BibTeX
@article{Giles2024,
  author = {Giles, Kristina A and Farber, Alik and Menard, Matthew T and Conte, Michael S and Nolan, Brian W and Siracuse, Jeffrey J and Strong, Michael B and Doros, Gheorghe and Venermo, Maarit and Azene, Ezana and Rosenfield, Kenneth and Powell, Richard J},
  title = {Surgery or endovascular therapy for patients with chronic limb-threatening ischemia requiring infrapopliteal interventions},
  journal = {Journal of Vascular Surgery},
  year = {2024},
  volume = {80},
  number = {5},
  pages = {1515--1524},
  doi = {10.1016/j.jvs.2024.05.049}
}
Kostenlos starten →